Envoy Medical logo

Envoy Medical

COCH | NASDAQ
Chart Builder DCF Calculator
$6.78
+$0.04 (+0.67%)
At close: Nov 16, 2026, 3:59 PM ET
$6.86
+$0.08 (+1.18%)
After-hours: Nov 16, 2026, 6:39 PM ET
+0.67%

Rating

Updated: Nov 16, 2026
39.7
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #533/1021 (Top 52%)

Key Statistics

Market Data

Market Cap $52.51M
1D Range
6.70 6.97
52W Range
3.90 9.01

Valuation (TTM)

PE -1.82
PB -34.30
EV/EBITDA -1.96

Valuation (NTM)

Forward PE N/A
Forward PEG 0.02
Price Target $2.00
Loading financial charts...

Profile

Envoy Medical, Inc. is a healthcare company dedicated to developing innovative medical technologies that address the full spectrum of hearing loss. Its diverse product portfolio includes conventional ...

Sector Healthcare
Employees 43
IPO Date Apr 29, 2021
Fiscal Year January - December

Latest News

Envoy Medical Updates Third Quarter 2026 Earnings Call Time to 8:00 A.M. ET on Thursday, November 5th

20 days ago · newsfilecorp.com

Envoy Medical Updates Third Quarter 2026 Earnings Call Time to 8:00 A.M. ET on Thursday, November 5th
Envoy Medical to Report Third Quarter 2026 Financial Results on Thursday, November 5th

21 days ago · newsfilecorp.com

Envoy Medical to Report Third Quarter 2026 Financial Results on Thursday, November 5th
Envoy Medical Announces Reverse Stock Split

26 days ago · newsfilecorp.com

Envoy Medical Announces Reverse Stock Split
Envoy Medical Hits Six-Month Milestone, Marks Halfway Point in Final Stage of Data Collection, and Highlights Differentiated Device Design

28 days ago · newsfilecorp.com

Envoy Medical Hits Six-Month Milestone, Marks Halfway Point in Final Stage of Data Collection, and Highlights Differentiated Device Design
Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant

1 month ago · newsfilecorp.com

Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant
Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio

2 months ago · newsfilecorp.com

Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio
Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th

3 months ago · newsfilecorp.com

Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th
Envoy Medical, Inc. (COCH) Reports Q2 Loss, Misses Revenue Estimates

3 months ago · zacks.com

Envoy Medical, Inc. (COCH) Reports Q2 Loss, Misses Revenue Estimates
Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones

3 months ago · newsfilecorp.com

Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones

Earnings

Latest Earnings
Nov 5, 2026
EPS
-$0.5
Beat +25.74%
REV
$66K
Beat +27.74%
Next Earnings
Mar 22, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$2.00
Downside
-70.50%
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.